Lupus-like manifestations in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) represent a distinct inflammatory syndrome driven by clonal hematopoietic cells rather than ...

In PV and ET, MDS risk remains lower than AML risk but increases progressively with advancing attained age. Transformation to acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) in ...

Dr. Shaal Patel, a board certified physician in hematology, oncology, and internal medicine, spoke with Healthline about how myelodysplastic syndromes (MDS) can benefit from supportive therapy, ...

MNV-201, a mitochondrial cell therapy, received FDA fast track designation for myelodysplastic syndrome, highlighting its potential to address mitochondrial dysfunction in this serious blood disorder.

Please provide your email address to receive an email when new articles are posted on . Olutasidenib monotherapy or combination therapy may help certain patients with myelodysplastic syndrome achieve ...

Results show that it may be beneficial to add longitudinal monitoring of kidney function to the management of patients with MDS. Myelodysplastic syndromes (MDS) are associated with a substantially ...

Elritercept is an activin receptor type IIA-Fc fusion protein designed to increase RBC and platelet production by inhibiting the signaling of a subset of the TGF-ß family of proteins to promote ...

Findings showed 23.8% in the tamibarotene/azacitidine group achieved CR compared with 18.8% in the placebo/azacitidine group (P =.2084). Syros Pharmaceuticals ...

Tobacco smoking is linked to specific genetic mutations in MDS, affecting chromatin modification and RNA splicing pathways. A dose-response relationship exists, with higher smoking intensity ...